NRXS - NeurAxis Inc. Qarzning balans kapitallashuviga nisbati

NeurAxis, Inc. (NRXS) kompaniyasining korporativ logotipi

NeurAxis, Inc. (NRXS) daromadlari pediatriyada texnologiyalarning joriy etilish sur'atiga bog'liq. Kompaniyaning qarzning kitob qiymatiga nisbati joriy tendentsiyalarni aks ettiradi, bunda 0.04 qiymati qarzning kapitalga nisbatdagi joriy miqdorini ko'rsatadi. AQSHda sug'urta qamrovining kengayishi mijozlar bazasini oshirmoqda, "razor-and-blade" modeli esa klinikalarning sarf materiallarini doimiy ravishda xarid qilishi orqali barqaror marjalarni ta'minlaydi.

NeurAxis, Inc. (NRXS) - Balans qiymatiga qarzlar 21.02.2024dan 27.10.2026gacha

NeurAxis Inc. (NRXS) boʻyicha maʼlumotlarning jamlanma tahliliy kesimlari

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya kotirovkalari NeurAxis, Inc.|NRXS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati NeurAxis Inc|NRXS - Qarz va naqd pullar hisobga olingan qiymat
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya uchun sof aktivlar NeurAxis|NRXS - Kompaniyaning xususiy kapitali|Bozor qiymatining balans qiymatiga nisbati neuraxis.com|NRXS - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati NeurAxis, Inc.|NRXS - Uzoq muddatli majburiyatlarning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati NeurAxis, Inc|NRXS - Kompaniyaning jamlangan qarzlari|Qarzning balans kapitallashuviga nisbati NeurAxis Inc
Kompaniyaning jamlanma tahliliyoti:NRXS, NeurAxis, Inc.
NeurAxis Inc yetakchi tovari

NeurAxis, Inc. (NRXS) moliyaviy barqarorligi qarz kapitali va o'z kapitali o'rtasidagi muvozanatga asoslangan. Ushbu ko'rsatkich leveraj darajasini aniqlash uchun umumiy majburiyatlarni o'z kapitalining balans qiymati bilan solishtiradi. IB-Stim texnologiyasini kengaytirish jarayonida to'lov qobiliyatini baholash uchun investorlarning ushbu koeffitsiyentni kuzatib borishi juda muhimdir. Qarzni optimallashtirish kompaniyaga jiddiy xatarlarsiz dori-darmonsiz terapiyani ishlab chiqish imkonini beradi. Dinamik qarzning kapitalizatsiya qiymatiga nisbatini tahlil qilish orqali emitentning kreditga layoqatliligini baholash mumkin.

NeurAxis, Inc. raqobatchilari

Qarzning balans qiymatiga nisbati BIIB (Biogen Inc.)|neurocrine.com - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Regencell Bioscience Holdings Limited (RGC)|AXSM: Qarzning sof aktivlarga nisbati|Qarzning balans kapitallashuviga nisbati ACAD|XENE (Xenon Corp) - Balans qiymatiga qarzlar|Qarzning balans kapitallashuviga nisbati Viking Therapeutics (VKTX)|Qarzning balans qiymatiga nisbati supernus.com|Catalyst Pharmaceuticals, Inc. - Balans kapitallashuviga qarzlar|Balans qiymatiga qarzlar Denali DNLI|Qarzning balans qiymatiga nisbati HRMY (Harmony Pharma)|Biohaven Corp - Balans kapitallashuviga qarzlar|Qarzning balans kapitallashuviga nisbati Amylyx Pharmaceuticals (AMLX)|TRVI - Qarzning sof aktivlarga nisbati|PRAX: Balans kapitallashuviga qarzlar|Balans kapitallashuviga qarzlar Anavex|Qarzning balans qiymatiga nisbati CeriBell Corp (CBLL)|Qarzning balans qiymatiga nisbati prothena.com|ALEC (Alector, Inc.) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar ANNX (annexonbio.com)|Qarzning balans kapitallashuviga nisbati OMER|NGNE - Sof aktivlarga qarzlar|Qarzning balans qiymatiga nisbati AC Immune Corp (ACIU)|VYGR - Qarzning sof aktivlarga nisbati|Neumora Therapeutics - Balans kapitallashuviga qarzlar|SCLX (scilexholding.com) - Sof aktivlarga qarzlar|Qarzning balans kapitallashuviga nisbati Tevogen Bio (TVGN)|Qarzning balans qiymatiga nisbati Alpha Cognition Corp|Balans kapitallashuviga qarzlar CGTX (Cognition Therapeutics)|Qarzning balans qiymatiga nisbati Inhibikase Pharma IKT|Qarzning balans qiymatiga nisbati SAVA|Assertio Holdings - Sof aktivlarga qarzlar|Coya (COYA) - Qarzning balans kapitallashuviga nisbati|VTGN: Qarzning balans qiymatiga nisbati|Qarzning balans kapitallashuviga nisbati ovidrx.com OVID|Qarzning sof aktivlarga nisbati Acumen Pharmaceuticals, Inc|Qarzning balans qiymatiga nisbati CervoMed Inc. (CRVO)|Qarzning balans qiymatiga nisbati ATHE|CLNN (Clene Inc.) - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar PEPG (pepgen.com)|JUNS - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Relmada Corp RLMD|ANVS (Annovis Bio, Inc.) - Balans kapitallashuviga qarzlar|Grace Therapeutics, Inc. (GRCE) - Balans qiymatiga qarzlar|AIFF: Qarzning balans qiymatiga nisbati|KLTO (Klotho Neurosciences) - Balans kapitallashuviga qarzlar|NRSN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati RVPH|MetaVia Inc - Qarzning balans kapitallashuviga nisbati|Balans qiymatiga qarzlar HSDT (heliusmedical.com)|PASG - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Neuphoria Therapeutics, Inc. NEUP|NERV (Minerva Neurosciences Corp) - Balans kapitallashuviga qarzlar|Athira Pharma Corp (ATHA) - Balans qiymatiga qarzlar|ADXN: Qarzning balans qiymatiga nisbati|ALZN (Alzamend Neuro) - Balans kapitallashuviga qarzlar|CYCN - Qarzning balans kapitallashuviga nisbati|Qarzning sof aktivlarga nisbati Protagenic|Balans kapitallashuviga qarzlar KTTA|Balans kapitallashuviga qarzlar cortigent.com CRGT|ATXI - Qarzning balans qiymatiga nisbati|Qarzning balans qiymatiga nisbati brainstorm-cell.com BCLI|Balans kapitallashuviga qarzlar CARA (Cara Therapeutics)|CHRO: Sof aktivlarga qarzlar|eliemtx.com - Qarzning balans kapitallashuviga nisbati|Sof aktivlarga qarzlar Intra-Cellular Therapies, Inc.|LBPH - Qarzning balans qiymatiga nisbati|Qarzning sof aktivlarga nisbati marinuspharma.com|NKGN (NKGen Biotech) - Balans kapitallashuviga qarzlar|Sof aktivlarga qarzlar NRBO (NeuroBo Pharmaceuticals Inc)|SAGE - Qarzning balans kapitallashuviga nisbati|Qarzning balans qiymatiga nisbati Synaptogenix, Inc SNPX|TRVN: Balans kapitallashuviga qarzlar|Vigil Neuroscience (VIGL) - Qarzning balans qiymatiga nisbati|Anew Medical - Qarzning balans qiymatiga nisbati|CERE (Cerevel Therapeutics Inc) - Sof aktivlarga qarzlar